NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Update

NovAccess Global Inc. (OTCMKTS:XSNX) was the target of a large growth in short interest in October. As of October 15th, there was short interest totalling 17,300 shares, a growth of 408.8% from the September 30th total of 3,400 shares. Based on an average daily trading volume, of 87,100 shares, the days-to-cover ratio is presently 0.2 days.

NovAccess Global Stock Performance

XSNX stock remained flat at $0.00 on Friday. NovAccess Global has a 52 week low of $0.00 and a 52 week high of $0.06. The firm has a market capitalization of $178,400.00, a price-to-earnings ratio of -0.03 and a beta of 1.82. The business has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01.

About NovAccess Global

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.